Methylprednisolone or Intravenous Immunoglobulin in Children with Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS)?: Pediatric Rheumatologist's Viewpoint

Indian Pediatr. 2023 Jul 15;60(7):574-575.

Author

Narendra Kumar Bagri¹

Affiliation

¹ Division of Pediatric Rheumatology, Department of Pediatrics AIIMS, New Delhi. drnarendrabagri@yahoo.co.in.

PMID: 37424122

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Child
Humans
Immunoglobulins, Intravenous / therapeutic use
Methylprednisolone / therapeutic use
Rheumatologists
SARS-CoV-2

Substances

Immunoglobulins, Intravenous
Methylprednisolone

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related